Andrew Schultz is Executive Vice President, Sales & Commercial Strategy at BrightInsight, where he helps healthcare and life sciences organizations harness digital innovation to deliver more personalized, connected, and patient-centered experiences at scale. He brings a career-long focus at the intersection of healthcare, technology, and commercial strategy, leading teams that transform how care is delivered, experienced, and monetized.
In his current role, Andrew partners with biopharma, medtech, and digital health leaders to shape commercial strategy, accelerate platform adoption, and unlock enterprise value through data-driven, compliant digital solutions. He is known for turning early-stage concepts into scalable growth engines, building high-performing commercial and product teams, and designing go-to-market models that create enduring competitive advantage.
Previously, Andrew served as President of PatientPoint Precision and Chief Product & Strategy Officer at PatientPoint, where he led integrated strategy, product, marketing, and creative organizations and helped scale one of the industry’s leading point-of-care engagement platforms. Before that, he focused on large-scale digital transformation, innovation, global marketing, and strategy at AmerisourceBergen (now Cencora) and leading healthcare agencies.
Across these roles, Andrew has built a reputation as a digital health innovator and growth leader who excels at aligning vision, product, and commercial execution to drive measurable impact for patients, providers, and industry partners. He holds an Executive MBA in Global Strategy & Management from Villanova University and a BA in Design & Art History from McDaniel College.